<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 170 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 107 in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase (CP) and 63 in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blastic phase</z:e> (BP) of the disease, 187 patients with "de novo" <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 175 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 164 patients with primary and 11 with <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e>, were cytogenetically examined </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:mp ids='MP_0005481'>CML</z:mp> were Ph positive, additional chromosomal changes were ascertained in 29% of patients in CP and in 71% of patients in BP </plain></SENT>
<SENT sid="2" pm="."><plain>The most frequent chromosomal abnormalities were <z:mp ids='MP_0004027'>trisomy</z:mp> 8, additional Ph, (i(17q] and loss of Y chromosome </plain></SENT>
<SENT sid="3" pm="."><plain>More favorable course of the disease was observed for group of patients with Ph chromosome as solitary chromosomal abnormality in CP </plain></SENT>
<SENT sid="4" pm="."><plain>Acquired chromosomal aberrations were proved in 137 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (73.3%) </plain></SENT>
<SENT sid="5" pm="."><plain>Except specific chromosomal changes delineated according to the specific subtype of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> we were concerned with evaluation of nonrandom chromosomal abnormalities, specially those involving chromosome 5 and 7 </plain></SENT>
<SENT sid="6" pm="."><plain>Numerical and morphological changes of those chromosomes were found in 33 patients (17.6%) </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients abnormal chromosomal clones were found in 68.8% of patients, those involving chromosome 5 and/or 7 in 68 patients (38.8% of <z:hpo ids='HP_0000001'>all</z:hpo> examined) </plain></SENT>
<SENT sid="8" pm="."><plain>The frequency of these abnormalities in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> does not differ significantly from the results quoted by the other studies </plain></SENT>
<SENT sid="9" pm="."><plain>However, in our <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients these so called "<z:chebi fb="1" ids="25435">mutagen</z:chebi>-associated" chromosome abnormalities were significantly more frequent than in <z:hpo ids='HP_0000001'>all</z:hpo> studies published so far </plain></SENT>
<SENT sid="10" pm="."><plain>Prognostic value of cytogenetic examination was evaluated on the basis of cumulative survival of patients with <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal chromosomal clones present in bone marrow cells </plain></SENT>
</text></document>